id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-339854-scb7pz87	Overend, Christopher	The synthetic futures of vesicular stomatitis virus	2012-07-11		.txt	text/plain	1089	77	42	Vesicular stomatitis virus (VSV) is one of the most promising viruses for engineering vaccines and oncolytic therapies [2] . Of particular interest is a study in which VSV expressing the H5 antigen from highly pathogenic avian influenza induced sterilizing immunity against heterologous challenge in mice [4] . This demonstrates the safety and efficacy potential of VSV when live virus vaccination would otherwise be contraindicated. Even more promising, recombinant VSV expressing a secreted form of a virulence factor protein for Yersinia pestis, LcrV, induced high levels of LcrV-specific antibodies, protecting 90% of the mice challenged with 10 LD 50 [6] . Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine SARS vaccine based on a replicationdefective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector	./cache/cord-339854-scb7pz87.txt	./txt/cord-339854-scb7pz87.txt